aga2118
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 28, 2022 (NCT05225857)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06577935 | Phase 2 | Oct 31, 2024 | Angitia Biopharmaceuticals, Angitia Incorporated Limited |
| NCT05225857 | Phase 1 | Jun 28, 2022 | Angitia Biopharmaceuticals, Angitia Incorporated Limited |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Angitia Biopharmaceuticals | For profit | 2 | 2 | 2 | 2022 |
| Angitia Incorporated Limited | For profit | 2 | 0 | 2 | 2022 |
2 organizations
Page 1 / 1